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Abstract 
Background: Exosomes are considered key elements for communication between cells, but very little is known 
about the mechanisms and selectivity of the transference processes involving exosomes released from different cells.
Results: In this study we have investigated the transfer of hollow gold nanoparticles (HGNs) between different cells 
when these HGNs were loaded within exosomes secreted by human placental mesenchymal stem cells (MSCs). 
These HGNs were successfully incorporated in the MSCs exosome biogenesis pathway and released as HGNs-loaded 
exosomes. Time-lapse microscopy and atomic emission spectroscopy allowed us to demonstrate the selective 
transfer of the secreted exosomes only to the cell type of origin when studying different cell types including cancer, 
metastatic, stem or immunological cells.
Conclusions: In this study we demonstrate the selectivity of in vitro exosomal transfer between certain cell types 
and how this phenomenon can be exploited to develop new specific vectors for advanced therapies. Specifically, 
we show how this preferential uptake can be leveraged to selectively induce cell death by light-induced hyperther-
mia only in cells of the same type as those producing the corresponding loaded exosomes. We describe how the 
exosomes are preferentially transferred to some cell types but not to others, thus providing a better understanding to 
design selective therapies for different diseases.
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Background
The body of an adult person contains around 37 billion 
cells that function coordinately [1]. To work as a whole 
entity many coordination mechanisms co-exist, using dif-
ferent factors as messengers. For example, the nervous 
system makes a strong use of communication by electri-
cal impulses and the endocrine system is capable to send 
messages to distant areas mediated by hormones [2]. One 
of the most intensely studied at the moment concerns the 
exchange of genetic material and proteins mediated by 
exosomes or microvesicles secreted by the cells [3].
Many cell types present in the organism release vesi-
cles of different nature, including apoptotic bodies, 
ectosomes, microvesicles and exosomes. Exosomes 
were known since 1981 when Trams and coworkers [4], 
defined exosomes as vesicles derived from the exfo-
liation of the plasmatic membrane, although the term 
“exosome” was coined in 1987 [5]. Early studies usually 
considered exosomes as “the garbage of the cells”, even 
though it was known that they contained genetic mate-
rial (including mRNA, miRNA, DNA and proteins). 
Eventually, it was discovered that exosomes not only 
could serve as a mechanism to discharge unwanted 
material from cells, but also could form the basis of an 
efficient cell–cell communication mechanism [3, 6]. For 
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instance, Valadi et al. showed that exosomal mRNA and 
micro RNA could be transferred to another cell being 
functional in this new localization [7].
Recent works dealing with the properties and functions 
of cell-derived exosomes suggest that they are involved in 
a variety of scenarios, including central nerve system dis-
eases, myocardial ischemia/circulation damage, liver and 
kidney injury and the modulation of tumor hallmarks, 
inducing angiogenesis and metastasis [8]. Their role in 
cell physiology processes as immune-modulators and in 
regenerative processes in the body for the normal hemo-
stasis maintenance has also been addressed [9]. Study-
ing exosomal transfer between cells could provide key 
information on the evolution of different diseases. They 
also hold promise as a tool for allowing early diagnosis 
[10], since exosomes are present in most biological fluids 
(blood, urine, saliva, sperm, etc.) and therefore a variety 
of tests could be developed.
Another highly important characteristic of exosomes 
relates to their role as transference vectors of mem-
brane receptors, functional proteins as growth factors or 
nucleic acids [11]. If this specific exosome-based trans-
port could be controlled, it could be potentially used to 
transfer therapeutic elements (drugs, virus, nanopar-
ticles, etc.). In fact, some investigations have already 
explored this path, harvesting exosomes and loading 
them with the desired therapeutics. Thus, Tian et  al. 
used electroporation to load doxorubicin into exosomes 
derived from mouse immature dendritic cells, and then 
the drug-containing exosomes were targeted to tumors 
in  vivo [12]. Similarly, Kim et  al. used mild sonication 
to load paclitaxel into macrophage-produced exosomes 
and reported that the loaded exosomes could be used to 
treat carcinomas at lower drug doses than the ones used 
in conventional treatments [13]. However, electropora-
tion and sonication can disrupt the exosomal membrane, 
and therefore other routes that exploit natural uptake 
mechanisms are preferred. Pascucci et al. were probably 
the first to show that an active drug (paclitaxel) could 
be selectively up taken by mesenchymal stem cells and 
then incorporated into the released exosomes in suffi-
cient concentration to inhibit the growth of  tumor cells 
in  vitro [14]. Altanerova et  al. reported the use of mes-
enchymal stem cells derived exosomes for magnetic 
hyperthermia applications in cancer therapy [15]. To this 
end, they added Venofer, an iron-sucrose complex, to the 
culture medium of mesenchymal stem cells and isolated 
the exosomes produced, which contained significant 
amounts of iron. This enabled them to induce magnetic 
hyperthermia by incubating tumoral cells with iron-con-
taining exosomes.
The therapeutic potential of exosomes has prompted 
a number of exosome-based treatments now being 
explored in clinical trials for diverse pathologies, includ-
ing sepsis, diabetes, cancer, wound healing or stroke. A 
recent search retrieved 78 current clinical trials involving 
exosomes as tools for diagnosis or therapy [16]. However, 
in spite of the fact that most of the proposed applications 
focus on the ability of exosomes to target specific cells or 
tissues, the understanding of their selective trafficking 
and communication mechanisms remains poor. In fact, 
the nature of selective fingerprinting of exosomes is still 
the subject of intense debate [17–19]. Some of the few 
works on this matter suggests that extracellular vesicles, 
including exosomes, can be incorporated by every cell 
type studied [20] but others show that exosomes can be 
used as drug carriers thanks to their ability to selectively 
target cells [21]. Rana et  al. demonstrated that the exo-
somal tetraspanin-complexes define the acceptor ligand 
in cells, and consequently are involved in cell selection 
[21]. Toda et  al. compared the internalization efficiency 
of U251- and astrocyte derived exosomes in U251 cells 
observing that the uptake of astrocyte derived exosomes 
was significantly lower than that obtained for U251-
derived exosomes [22]. Hazan-Halevy et  al. showed a 
cell-specific uptake of MCL exosomes by normal and by 
MCL derived patients’ B-lymphocytes [23].
Herein we have used relatively large entities (40 nm in 
diameter hollow gold nanoparticles (HGNs)) as tools to 
monitor the exosomal transference between cells. HGNs 
are especially suitable given the properties of gold (chem-
ical inertness, biocompatibility and low toxicity), but also 
because HGNs present surface plasmon resonance (SPR) 
in the near-infrared region. As a consequence, when 
exposed to light with a suitable wavelength (ca. 700 to 
1000 nm) HGNs behave as efficient transductors of light 
into heat, and can be used to destroy malignant cells by 
hyperthermia or to trigger other temperature-driven pro-
cesses, including drug delivery and gene expression [24–
26]. We have successfully incorporated HGNs into the 
MSC exosome biogenesis pathway. Using HGN-loaded 
exosomes, we were able to follow cell–cell communica-
tion, and in particular how the exosome cellular origin 
could affect HGNs transference between cells. We inves-
tigated whether HGN-loaded exosomes were similarly 
or differentially incorporated by cancer cells, metastatic 
cells, human placental mesenchymal stem cells (MSCs) 
and cells from the mononuclear phagocyte system (MPS). 
Our results indicate that the exosomal envelope is key to 
maintain the identity and compatibility of transference, 
providing a fingerprint that is responsible for the trans-
fer selectivity. Finally, we have exploited this preferential 
transfer to selectively induce death by hyperthermia only 
in specific cells.
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Results
Hollow gold nanoparticles characterization
Transmission electron microscopy (TEM) images of the 
as-prepared nanoparticles (NPs) are shown in Fig.  1. 
The HGNs were hollow pseudo-spheres with a thick 
shell (Fig.  1a), and after polyethylene glycol (SH-PEG) 
functionalization, a uniform shell of almost 5  nm could 
be observed coating the HGNs. The mean diameter of 
HGNs obtained from the TEM images was 38.3 ± 8.3 nm, 
whereas the mean size of PEGylated NPs (PEG-HGNs) 
(determined by negative staining the TEM sample) was 
44.9 ± 7.6  nm. Both HGNs and PEG-HGNs showed a 
characteristic localized surface plasmon resonance peak 
in the NIR region around 850 nm (Fig. 1b). A slight red 
shift was observed for the PEGylated NPs, possibly 
attributed to a different dielectric value in the interfa-
cial double layer coating on the NPs [27]. Phase analysis 
light scattering measurements (not shown) showed that 
at pH = 7 the surface charge for the HGNs in water was 
− 15.35 ± 0.84 mV and compared to the one obtained for 
the PEG-HGNs (− 10.48 ± 0.35  mV) corroborated the 
efficient PEG coating on the particles surface.
The  biological characterization of both HGNs and 
PEG-HGNs is thoroughly described  in Additional file  1 
section. The stability and the aggregation state of both 
HGNs and PEG-HGNs in cell culture media supple-
mented with 10% FBS was initially evaluated. Additional 
file 1: Figure S1A shows TEM images of both naked and 
PEGylated NPs after being in contact with cell culture 
media for 24  h (naked HGNs were significantly more 
aggregated than the PEGylated ones). In order to study 
the amount of protein adsorbed on the NPs, the bicin-
choninic acid (BCA) assay was performed on both NP 
populations in cell culture media supplemented with 10% 
FBS. Additional file  1: Figure S1B evidences that in the 
case of HGNs the total protein amount adsorbed on their 
surfaces increased over time. On the contrary, the pro-
tein adsorption on PEGylated NPs was significantly lower 
compared to the amount adsorbed on naked HGNs in 
agreement with the well known steric hindrance attrib-
uted to PEG.
To corroborate this observation, the zeta poten-
tial of both NP-based dispersions in cell culture media 
was also measured, obtaining zeta potential values of 
− 3.64 ± 2.73  mV and − 8.50 ± 1.50  mV for HGNs and 
PEG-HGNs, respectively (Additional file  1: Figure S1C) 
which is indicative of a higher protein adsorption on the 
bare nanoparticles, shielding electric charge and giving 
zeta potential values closer to the isoelectrical point.
Fig. 1 Characterization of HGNs and PEG-HGNs. a TEM images of HGNs and PEG-HGNs (above). PEG functionalization is clearly visible around the 
nanospheres by a negative staining to contrast the organic shell. Size distribution diagram of NPs obtained from TEM images (bottom). b UV–VIS 
absorption spectra for both types of nanoparticles. A maximum absorbance peak was observed at 850 nm, corresponding with the geometrical 
shape and size of these NPs
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The dose-dependent viability of MSCs was evalu-
ated under the presence of HGNs and PEG-HGNs by a 
metabolic assay. Additional file  1: Figure S2A reveals 
that 0.125  mg  mL−1 was the limit for the subcytotoxic 
effect. Furthermore, we also confirmed that the presence 
of both types of NPs in the cell cultures did not produce 
significant changes on cell cycle phases at the subcyto-
toxic doses (Additional file  1: Figure S2B). Finally, the 
presence of the NPs inside MSCs was evaluated by con-
focal microscopy (Additional file 1: Figure S2C) and was 
indirectly quantified by MP-AES using the total amount 
of gold measured inside the cells (Additional file 1: Fig-
ure S2D). These results indicate that significantly more 
PEG-HGNs were localized inside cells compared to the 
amounts retrieved for HGNs, probably due to the higher 
stability and reduced agglomeration in the culture media 
provided by the PEG-surface functionalization. A better 
dispersion might increase the chances of nanoparticle 
internalization. Going deeper on HGNs uptake by MSCs, 
we also evaluated the preferential pathways that PEG-
HGNs followed in the process of being incorporated into 
the target cells to verify if those strategies were compat-
ible with the exosomal pathway. Additional file 1: Figure 
S3 reveals that not only clathrin-mediated endocytosis, 
but also other energy-dependent pathways were the main 
internalization mechanisms involved in the PEG-HGNs 
capture by MSCs, and therefore nanoparticles could be 
efficiently incorporated into the target cells.
Secretion of empty and HGN-loaded exosomes by MSCs
Before attempting to encapsulate HGNs within exosomes, 
we characterized MSCs derived exosomes (MSCs-EXOs) 
by physico-chemical  and biological techniques. TEM 
images of MSCs-EXOs isolated from culture superna-
tants by successive ultracentrifugation steps are shown in 
Fig.  2. A spherical shape and a characteristic lipidic bi-
layer membrane were observed in most of them. The size 
distribution histograms of exosomes obtained from TEM 
images, gave an average diameter of 113.2 ± 45.6  nm. 
Dynamic light scattering (DLS) and nanoparticle track-
ing analysis (NTA) measurements gave a mean particle 
diameter around 180  nm in PBS. The measured surface 
charged of exosomes at pH 7 was − 8.28 ± 3.42 mV likely 
due to the negatively charged phospholipids and proteins 
present on the exosomal membrane.
Incorporation of HGNs into MSCs-derived exosomes
We have used confocal microscopy to monitor the asso-
ciation of HGNs with exosomes. To this end, exosomes 
were labeled with a specific CD63-Alexa488 antibody 
(blue) the cell nuclei with Draq-5 (yellow) and the HGNs 
agglomerates were directly observed by reflection (red) 
(Fig.  3a). Orthogonal projections from confocal laser-
scanning microscopy analysis revealed high purple fluo-
rescence pixels on the MSCs cytoplasm, i.e., the merging 
of the blue and red fluorescence, which corresponds with 
aggregates of NPs and exosomes or late endosomes co-
localization, indicating that multivesicular bodies within 
the cell already contain HGN-loaded exosomes. After 
Fig. 2 Characterization of MSCs-EXOs produced in the absence of HGNs. a Representative TEM images of an exosome sample isolated from MSCs 
cells supernatants. In the bottom image the double lipid membrane is clearly visible. b Size distributions derived from TEM images (above) and from 
DLS (bottom). c NTA results of MSCs_EXOs in PBS
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these were excreted, the HGN-loaded exosomes could be 
easily recovered by ultracentrifugation and subjected to 
TEM analysis. TEM images of purified exosomes from 
MSCs culture supernatants after incubation with PEG-
HGNs showed that most exosomes were loaded with 
at least one nanoparticle, confirming the high yield of 
nanoparticle loading into exosomes (Fig. 3b). The diam-
eter distribution histogram of PEG-HGNs_MSCs-EXOs 
obtained from TEM images revealed average sizes of 
126.9 ± 39.2  nm. These values confirmed that the pres-
ence of the NPs inside the exosomes did not affect their 
endogenous diameter. Furthermore, the size distributions 
obtained by NTA for control exosomes and for PEG-
HGNs_MSCs-EXOs (Figs. 2c, 3e, respectively) were also 
similar. The measured surface charged of PEG-HGNs_
MSCs-EXOs at pH 7 was − 10.26 ± 0.17  mV, confirm-
ing that the presence of the PEG-HGNs did not alter the 
Fig. 3 Location of PEG-HGNs in exosomes derived from MSCs. a Intracellular localization of HGNs and PEG-HGNs in MSCs by confocal microscopy. 
Most of the HGNs and PEG-HGNs co-localized with exosomes stained with CD63 antibody. There was also a smaller fraction of NPs inside the 
cytoplasm without co-localization with exosomes. Yellow represents nuclei stained by DAPI, blue are the exosomes labeled with CD63-488 
antibody, and NPs were directly visualized by reflection. b TEM images of exosomes purified (ultracentrifugation) from MSCs incubated with 
PEG-HGNs for 48 h and size distribution histogram. Most exosomes were loaded with NPs. c Western Blot of MSCs derived exosomes with or 
without PEG-HGNs. d Total protein exosomes quantification by BCA assay when cells were treated under the presence or absence of PEG-HGNs. e 
NTA measurements of exosomes sizes and concentrations
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negatively charged phospholipids and proteins present 
on the exosomal membrane. Western Blot analysis of 
isolated vesicles showed expression of the exosome-asso-
ciate proteins CD9 and CD63 [signal at 21 and 53  kDa 
respectively, were clearly observed (Fig.  3c)]. Compar-
ing total protein amounts obtained by the BCA (Fig. 3d) 
and exosomes concentration measured by NTA (Fig. 3e), 
higher amounts of exosomes were significantly secreted 
when cells were treated with NPs compared to the 
amounts measured for control samples (untreated cells).
Exosomes as specific vectors of PEG-HGNs 
between different cell lines
Given the way nanoparticle-loaded exosomes are gen-
erated, we postulated that exosomes derived from a 
cell line are fingerprinted with hallmarks of that cell 
type and therefore would be preferentially up-taken 
by the same cell line, even under co-culture condi-
tions with other cell lines. To verify if exosomes from 
a cell line were specifically captured by the same cell 
line we developed a co-culture of stem cells and mono-
cytes under optimized conditions for their simultane-
ous growth. To facilitate identification, both types of 
cells were labeled with PKH67 (green) and PKH26 (red) 
dyes, respectively (Additional file  1: Figure S4). Once 
co-cultures were optimized, the exchange of material 
between cells (i.e., the intercellular trafficking among 
MSCs and between MSCs and monocytes) could be 
easily followed by time-lapse microscopy thanks to the 
HGNs loaded inside the exosomes.
We performed time-lapse microscopy of MSCs and 
monocytes cultured separately (control) and co-cultured 
for 3  days to observe nanoparticle transference in real 
time. We also used MP-AES to determine the Au con-
tent of the different cell populations and supernatants 
in order to follow overall internalization of PEG-HGNs. 
Our results (Fig. 4) show that, when fresh nanoparticles 
(i.e. nanoparticles that had not previously been incubated 
with any type of cell) were added either to each cell type 
individually or to co-cultures containing simultaneously 
Fig. 4 NPs trafficking between different cell lines. a MP-AES assay to quantify nanoparticle distribution (gold content) between monocytes and 
MSCs when the PEG-HGNs were incubated simultaneously with either or with both cell types, when nanoparticles were previously incubated with 
MSCs, or when they were pre-incubated with monocytes. b A similar MP-AES series of experiments of gold distribution was carried out between 
tumoral (B16-F1) cells and monocytes. c Time-lapse images corresponding to the transfer of PEG-HGNs between MSCs (marked with blue and 
green dots). The frames have been selected because in both cases there were monocytes close by that did not take the passing by nanoparticles. 
Time-lapse videos showing these and other examples of selective transfer are available as Additional files 2 (PEG-HGNs added simultaneously) and 3 
(PEG-HGNs transference among MSCs)
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MSCs and monocytes, they were significantly up-taken 
by both cell types (between 1 and 2 μg of gold/cell popu-
lation). In contrast, when PEG-HGNs were pre-incubated 
in MSCs and then PEG-HGNs loaded exosomes were put 
in contact with monocytes, we observed that nanopar-
ticles transference occurs preferentially between MSCs 
and only a minor fraction of PEG-HGNs was captured 
by monocytes both at 24 h and 48 h (0.09 μg of gold/cell 
population at both times). The symmetric experiment 
was carried out by pre-incubating PEG-HGNs in mono-
cytes and co-culturing them with MSCs. In this case, the 
amount of gold nanoparticles internalized in MSCs was 
remarkably small, in spite of the fact that the supernatant 
concentration was  high (0.9  μg of gold/cell population), 
i.e. there was a large concentration of nanoparticles avail-
able. It is reported that when monocytic cells recognize 
nanoparticles in the media, as efficient scavengers, they 
firstly internalize NPs and trap them in the endosomal-
exosomal pathway releasing those materials again to 
the media [28]. Figure 4 shows that the majority of gold 
released to the media by monocytes remained in the 
media instead of being uptaken by MSCs, thus confirm-
ing the preservation of the self-signature of monocytes.
Moreover, the same trend was also observed in Addi-
tional file 1: Figure S5. Herein, we employed MP-AES to 
determine the specific capturing of previously purified 
PEG-HGNs loaded exosomes of different cellular origin. 
When MSCs derived exosomes loaded with PEG-HGNs 
(PEG-HGNs_MSCs-EXOs) were added to a co-culture 
of MSCs and monocytes, they were preferentially taken 
by MSCs (0.12 and 0.17 μg of gold/cell population at 24 h 
and 48 h, respectively) and only a minor fraction of PEG-
HGNs was internalized into monocytes (0.015 μg of gold/
cell population). In the symmetric experiment, (i.e. PEG-
HGNs were pre-incubated with monocytes and then the 
exosomes produced were released into the co-culture of 
MSCs and monocytes) the amount of gold nanoparti-
cles internalized in MSCs was remarkably small, in spite 
of the fact that the supernatant concentration was high 
(0.14  μg of gold/cell population). While the Au analysis 
results agree with the selective uptake of PEG-HGNs-
loaded exosomes according to their cellular origin, Fig. 4 
and Additional file 1: Figure S5 also seem to indicate that, 
to a lesser extent, some type of non-selective internaliza-
tion could also be taking place, since a small fraction of 
Au was observed to be internalized by non-related cells. 
However, this can be explained as a result of the uptake of 
free Au nanoparticles that either were present originally 
in the medium or were excreted through a non-exosomal 
pathway and therefore lack the cell-specific exosomal 
coating. These free HGNs were clearly present along with 
exosome-enclosed HGNs in the culture medium (see 
Fig. 3b).
To validate the conclusions reached with other cell 
types, the same study was carried out using monocytes 
and tumoral cells (B16-F1 cells) instead of MSCs. The 
results (Fig.  4) show that for separate cultures of each 
cell, the uptake of PEG-HGNs by monocytes was  sig-
nificantly (ca. 5 times) higher than that obtained for the 
tumoral cells. When cultured together, a similar uptake 
ratio is observed for both types of cells. However, when 
the gold nanoparticles were pre-incubated in B16-F1 cells 
and transferred to the co-culture with monocytes, only a 
small amount of PEG-HGNs was captured by monocytes 
(0.089 μg of gold/cell population). On the contrary, when 
PEG-HGNs were pre-incubated with monocytes and the 
resulting HGN-containing exosomes were put in contact 
with the co-culture of monocytes and B16-F1 cells, only a 
small fraction was captured by B16-F1 cells (0.042 μg of 
gold/cell population).
Time-lapse microscopy was used to obtain a direct 
confirmation of the conclusions obtained from MP-AES 
analysis regarding the selective uptake of PEG-HGNs 
according to their origin. To this end, MSCs were incu-
bated with PEG-HGNs and then the MSCs containing 
internalized nanoparticles were co-cultured with mono-
cytes. As can be seen in the frames presented in Fig. 4c 
and d, and in the movies included as Additional files 2 
and 3, a high amount of nanoparticles were present inside 
the MSCs, and those were very active in transferring 
nanoparticles between cells. However, tracking of the 
excreted material shows that the nanoparticles released 
by a donor MSC were mostly captured by another MSC 
and not by monocytes present in the proximity, even 
though monocytes were close by and often in the path of 
the released material. Therefore, a specific signature of 
the exosomes released from a cell type is conserved and 
used as recognition moiety for the same cell type.
Selective death by hyperthermia mediated 
using PEG-HGNs-loaded exosomes
As a proof of concept of the possibility of inducing 
selective cell death using the high intrinsic selectiv-
ity of exosome-mediated transport we analyzed the 
in  vitro photothermal effect of HGN-loaded exosomes 
originated from MSCs on separate cultures contain-
ing MSCs, melanoma cells (B16-F1 and B16-F10) and 
monocytes. To this end, MSCs were incubated with 
PEG-HGNs (0.1  mg  mL−1) and the resulting HGN-
containing exosomes were harvested and purified. Then 
cultures with the above cell lines were exposed to the 
loaded exosomes for 24 h (the PEG-HGNs_MSCs-EXOs 
concentration added to each well, was estimated as the 
ratio between the amount of donor cells from which 
those exosomes were derived (MSCs) and the number of 
treated cells). After washing, cell cultures were irradiated 
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with a NIR laser, and viability/toxicity was evaluated by 
flow cytometry as well as by direct live/dead staining.
In Fig. 5a, it is possible to observe that NIR laser irra-
diation did not significantly reduce cell viability on B16-
F1 cells, B16-F10 cells and monocytes that had been 
treated with PEG-HGNs containing exosomes derived 
from MSCs, i.e., they present the same viability as the 
control samples, (cells subjected to NIR irradiation in 
the absence of HGNs loaded exosomes). On the con-
trary, a reduction in viability of almost 50% was observed 
for irradiated MSCs after treatment with HGN-loaded 
exosomes derived from MSCs. Very similar results were 
obtained using a fluorescence inverted microscope to 
quantify live/dead cells after exposure to MSC-derived 
exosomes followed by NIR irradiation (Additional file 1: 
Figure S6). These results again confirm the high specific-
ity of exosome uptake depending on the exosomes origin. 
HGNs_MSCs-EXOs produced by seeded cells to treated 
cells, a decrease in the viability of approximately 70% was 
measured for irradiated MSCs demonstrating a dose-
dependent process. In contrast, the viability of B16-F1 
cells, B16-F10 cells and monocytes again was unaffected.
Finally, a further study was carried out to confirm 
selective exchange in the dynamic environment of a co-
culture system. To this end, MSCs previously loaded with 
PEG-HGNs were co-cultured with B16-F1 cells during 
48  h, a period sufficiently long to have multiple excre-
tions/uptakes of nanoparticles by MSCs. Figure 5b shows 
that, after laser irradiation, only MSCs were dead while 
B16-F1 were still alive. This selective photothermal effect 
confirmed the lack of exosomal exchange between B16-
F1 and MSCs also under co-culture conditions and this 
fact is consistent with our hypothesis of exosome finger-
printing according to the cellular origin.
Discussion
Thanks to the intrinsic size of the nanomaterials and 
considering the size of the cellular components and that 
most of the biological processes occur at the nanom-
eter scale, a novel and promising field has been opened. 
Thus, research on exosomes and NPs combination has 
gained  attraction over the last decade [29–31]. Several 
works have reported the unique propierties of HGNs 
as efficient transductors of light into heat, being used 
to destroy malignant cells by hyperthermia or to trigger 
other temperature-driven processes, such as drug deliv-
ery and gene expression [24–26]. Although exosomes are 
considered key elements for communication between 
cells, few studies are reported about the mechanisms 
and selectivity of the transference processes involving 
exosomes released from different cells [17, 18]. Herein 
we study the selectivity of in  vitro exosomal transfer 
between certain cell types and how this phenomenon can 
be exploited to develop new specific vectors for the trans-
fer of relatively large entities (40 nm in diameter HGNs) 
between different cells when these NPs were loaded 
within exosomes secreted by human MSCs.
As was previously reported by other authors, the mor-
phology and the plasmonic response of the HGNs and 
PEG-HGNs correspond with the ones described in the 
literature [32]. Amongst the characteristics of those NPs, 
the presence of SH-PEG coating is usually employed to 
provide a stealth cover to retard detection and removal 
by MPS macrophages by reducing the protein corona for-
mation around HGNs. Also, both NPs dispersions have 
a maximum resonance peak at 808  nm, in which the 
absorption of incident light is minimized in biological 
fluids because of the reduced light absorption by water 
and chromophores [33].
Regarding the cytotoxicity test and the cellular cycle 
analysis, our results indicate that the presence of both 
types of NPs did not produce significant effects on cell 
Fig. 5 Photothermal effects mediated by MSCs-derived exosomes containing plasmonic HGNs. a Quantification of cell death when MSCs, 
monocytes, B16-F1 and B16-F10 cell lines cells were treated with PEG-HGNs-containing exosomes derived from MSCs. b Photothermal effect in a 
co-culture of PEG-HGN containing MSCs and B16-F1 cells during 48 h before subjecting the culture to NIR irradiation
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viability and on cell cycle distribution at the studied dose. 
These results are in agreement with previous studies in 
our laboratory describing the lack of toxicity of HGNs 
and especially PEG-HGNs in tumoral cells, bone mar-
row derived stem cells and fibroblasts [34]. Moreover, the 
amount of particle uptake by MSCs after 24 h of incuba-
tion are within the wide interval found in previous inter-
nalization studies with different cells and particles (values 
reported ranged from  103 to  107 particles per cell) [35].
Both the size distribution histograms obtained and the 
DLS measurements obtained for MSCs-EXOs were in 
agreement with previously reported diameters of MSCs-
EXOs [36]. The measured surface charged of exosomes 
was attributed to the negatively charged phospholipids 
and proteins present on the exosomal membrane. This 
value was in accordance with previous literature [37].
In previous reports, it has been demonstrated that EVs 
enter cells by a variety of endocytic pathways, includ-
ing clathrin-dependent endocytosis, and  clathrin-inde-
pendent pathways such as caveolin-mediated uptake, 
macropinocytosis, phagocytosis, and lipid raft-mediated 
internalization [38]. Phagocytosis, clathrin-dependent 
endocytosis, caveolae-mediated endocytosis, endocyto-
sis toward receptors and pinocytosis are reported as the 
main cellular uptake pathways of NPs [39]. However, the 
mechanism may change depending on particle size, sur-
face chemistry and shape [40]. Also, even for the same 
type of NPs, the internalization mechanisms may be dif-
ferent for different cell lines [41]. As noted above, our 
results indicate HGNs and PEG-HGNs are internalized 
by MSCs following energy-dependent and clathrin-medi-
ated endocytosis processes. Furthermore, nanoparticles 
are localized within early endosomes after 5  h of incu-
bation. Soon afterwards PEG-HGNs can be observed 
within multi-vesicular bodies (MVB), and co-localize 
with exosomes labeled with a specific antibody (CD63). 
As previously shown, an intense production of exosomes 
loaded with PEG-HGNs was observed by CD9 and CD63 
expression by the BCA analysis and by the NTA results. 
These data indicate that the presence of PEG-HGNs 
within the cells did not significantly affect the protein 
content of exosomes. In fact, the intensity of the CD9 and 
CD63 bands was higher compared to the controls when 
MSCs were in contact with PEG-HGNs. These results 
were in accordance with the BCA and NTA analyses, 
which indicated that in presence of PEG-HGNs, MSCs 
exosomal protein secretion was enhanced compared to 
the control MSCs without added HGNs (Fig. 3d). Thus, 
it appears that when MSCs were incubated with HGNs, 
they release exosomes more intensely. This characteristic 
seems to agree well with earlier reports on the enhanced 
cell processes of MSCs exposed to PEG-HGNs [34].
Thereby, we have taken advantage of the intrinsic exo-
some biogenesis process to obtain exosomes loaded 
with gold NPs (Additional file  1: Scheme S1) by adding 
PEG-HGNs to the cell culture medium of MSCs. These 
vesicles could be recovered easily, since HGN-contain-
ing exosomes precipitated readily by ultracentrifuga-
tion. This loading process avoids harsh treatments such 
as membrane rupture by electroporation or chemi-
cal bonding on the membrane wall and is likely to pre-
serve better the natural characteristics of the produced 
exosomes. Few studies have attempted the encapsulation 
of preformed nanoparticles within exosomes, generally 
using exogenous methods to achieve encapsulation. For 
instance, Hood et al. [42], loaded superparamagnetic iron 
oxide nanoparticles (SPIONs) inside exosomes by elec-
troporation, obtaining B16-F10 derived exosomes loaded 
with 5 nm iron nanoparticles. They proposed the use of 
semi-synthetic exosomes for diagnosis or therapeutic 
applications. Furthermore, Hu et al. also used electropo-
ration to load SPIONs into B16-F10 derived exosomes 
for imaging and tracking by MRI in vitro and in vivo [29]. 
Also, several works have described the grafting of gold 
nanoparticles to the exosome surface via affinity agents 
such as lectins and antibodies [43]. Roma-Rodrigues et al. 
[44] used gold nanoparticles functionalized with thi-
olated oligonucleotides for selective silencing of RAB27A 
gene (essential gene for the biogenesis and processing 
of exosomes) with a consequent decrease of exosomes 
release. Other authors have employed more gentle or 
natural methods to load nanoparticles into exosomes. 
Thus, Alhasan et al. [30] loaded gold nanoparticle-nucleic 
acid constructs within exosomes by incubating them 
with prostate cancer cells and allowing endocytosis. A 
small fraction (< 1%) of the gold was then released inside 
exosomes, and could be recovered and re-introduced by 
exposing the cells to the recovered exosomes. In a differ-
ent approach, Betzer et al. used the GLT-1 transporter to 
induce loading of glucose-coated gold nanoparticles into 
exosomes as labels for in vivo neuroimaging [31].
Once nanoparticle-loaded exosomes were generated, 
we evaluated if those exosomes were fingerprinted and 
therefore would be preferentially captured by the same 
cell line, even under co-culture conditions with other 
cell lines. Both MP-AES evaluation and time-lapse image 
sequences demonstrate that the nanoparticles released 
by a donor MSCs were rather up-taken by another MSCs 
and not by monocytes present in the proximity. There-
fore a specific signature of the exosomes released from 
a cell type is conserved and used as recognition moiety 
for the same cell type. Although there are few works 
postulating that exosomes can be incorporated by every 
cell type [20], our results are in agreement with previous 
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works suggesting that exosomes have the ability to target 
specific cells and to serve as selective vehicles [21–23].
The highly selective transfer mechanism mediated by 
exosomes opens the possibility to use these vectors for 
targeted therapy. Nanoparticles are particularly attrac-
tive in a scenario of therapeutic nanoparticle delivery, 
since their loading within exosomes would help to avoid 
in vivo recognition by the MPS. As a proof of concept of 
the possibility of inducing selective cell death using the 
high intrinsic selectivity of exosome-mediated transport 
we analyzed the in  vitro photothermal effect of HGN-
loaded exosomes originated from MSCs on separate 
cultures containing MSCs, melanoma cells (B16-F1 and 
B16-F10) and monocytes. Our results again confirm the 
high specificity of exosome uptake depending on the 
exosomes origin (Fig.  5). The selective transference of 
exosomes loaded with NPs among the same cell line was 
also confirmed in the dynamic environment of a co-cul-
ture system observing that only MSCs were dead while 
B16-F1 were still alive after NIR irradiation when MSCs 
were loaded with PEG-HGNs and then were co-cultured 
with B16-F1. This selective photothermal effect clearly 
demonstrates the absence of exosomal exchange between 
tumoral and MSCs also under co-culture conditions, 
and is consistent with our hypothesis of exosome finger-
printing according to the cellular origin. To our knowl-
edge, this is the first work in which the specific transfer 
of exosomes is employed for selectively applied optical 
hyperthermia therapies.
Conclusion
The encapsulation of PEG-HGNs in exosomes using the 
intrinsic biogenesis pathways of MSCs allowed us to 
confirm the high specificity of exosome-mediated cell 
exchanges, according to the cell origin. A wide study has 
been carried out with cells of different lineage, includ-
ing stem cells, immune system cells, and tumor and 
metastatic cell lines. As a proof of concept of exosome-
mediated selective transfer of therapeutic material into 
the targeted cells, for the first time our study demon-
strates the specific in vitro optical hyperthermia therapy 
based on exosome delivery of NIR-responding plasmonic 
nanoparticles. Finally, we can conclude that considering 
the cell of origin and the compatibility of the target cells 




HGNs synthesis was carried out according to the proto-
col developed by Preciado-Flores et  al. [32] with slight 
modifications previously reported by Encabo-Berzosa 
et al. [34]. The complete synthesis protocol is described 
in Additional file 1 and the physico-chemical characteri-
zation of the nanoparticles was performed as previously 
reported [34].
Biological evaluation of NPs
To evaluate the stability of HGNs and PEG-HGNs in cell 
culture media at 0.125  mg  mL−1, the BCA assay (Ther-
moFisher, USA)  was performed as mentioned before to 
evaluate the total amount of proteins adsorbed on them. 
Moreover, their aggregation state was assessed by TEM 
and by Zeta potential analysis. Blue Cell viability assay ® 
(Abnova, USA) was employed to determine cell viability of 
MSCs under the effect of HGNs and PEG-HGNs [34]. To 
analyze the effects of HGNs and PEG-HGNs in cell cycle 
and in DNA damage, the distribution of cell cycle phases 
after NPs treatment was assessed by flow cytometry [34].
Cellular uptake of NPs by MSCs
Confocal microscopy, flow cytometry and MP-AES
The cellular uptake and the trafficking of nanoparticles 
in MSCs were evaluated by confocal microscopy and the 
amount of gold inside MSCs was quantified by MP-AES 
using a quadrupole ICP mass spectrometer (4100 MP-
AES, Agilent Technologies, USA) (see Additional file 1).
Identification of the cellular pathway
To study the specific internalization mechanism of NPs 
in MSCs, different uptake pathways were blocked with a 
variety of chemical inhibitors previously reported [45]. 
The presence or absence of HGNs and PEG-HGNs in 
MSCs under the effect of the different inhibitors was 
detected by Z-stack orthogonal projections obtained 
from confocal microscopy (Spectral Confocal Micro-
scope Leica TCA SP2) as mentioned above. For more 
details see Additional file 1.
Exosome isolation and characterization
MSCs-derived exosomes (MSCs-EXOs) were isolated fol-
lowing a protocol based on successive ultracentrifugation 
cycles from cell culture supernatants of MSCs throughly 
described in Additional file 1.
Gold nanoparticles-loaded exosomes
In order to obtain PEG-HGNs_MSCs-EXOs, cells were 
cultured with ultracen medium enriched with PEG-
HGNs at the subcytotoxic dose (0.125 mg mL−1) for 24 h. 
Then, the culture media was replaced by exosomes free 
medium for 48 h and excreted PEG-HGNs_MSCs-EXOs 
were purified from the supernatant as mentioned above. 
The presence of PEG-HGNs in exosomes was evalu-
ated by confocal microscopy and by TEM as detailed in 
Additional file 1. Protein expression (GAPDH, CD9 and 
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CD63) was evaluated by Western Blot analysis charging 
exosomes secreted by the same number of cells in order 
to be able to compare the protein expression when cells 
were treated or not with nanoparticles. A Pierce BCA 
protein assay was also performed as mentioned above 
to estimate the protein content in the exosomes sam-
ple secreted by MSCs when cells were treated or not 
with NPs. Furthermore NTA anlysis was carried out to 
evaluate the diameter and the number of particles per 
mL of control exosomes or PEG-HGNs_MSCs-EXOs. 
Exosomes measured by NTA were purified from the 
same number of cells under the presence or absence of 
PEG-HGNs.
Exosomes as selective vectors of PEG-HGNs uptake 
between different cell lines
Optimization of co-culture conditions by flow cytometry 
and fluorescence microscopy
The evaluation of PEG-HGNs transference through 
exosomes between monocytes and MSCs was assessed 
to study the potential use of exosomes as nanoparticle 
specific vectors between different cell lines. In order to 
optimize the co-culture conditions, specific cell surface 
markers of monocytes and MSCs (CD19, CD14, CD34, 
CD45, CD73, CD90, CD10 and, HLA-DR) were evaluated 
by flow cytometry (FACSAria BD cytometer, BD Biosci-
ence) when cells were cultured separately or together (see 
Additional file 1).
PEG-HGNs distribution between monocytes and MSCs
The in  vitro distribution of of PEG-HGNs_MSCs-
EXOs and monocytes derived exosomes loaded with 
nanoparticles (PEG-HGNs_monocyteexos), between 
both cell lines was visualized at real time by time-
lapse microscopy with a 20× objective (Leica AF6000 
LX, Germany). On the one hand, MSCs and mono-
cytes were cultured separately as control condition 
in an IBIDI μ-Slide 8 well at a density of 1 × 105 cells 
per well. On the other hand, 5 × 104 monocytes were 
co-cultured together with 5 × 104 MSCs in the same 
well for the co-culture samples. In these co-culture 
samples, two different experiments were carried out. 
First, the uptake and the in  vitro distribution of PEG-
HGNs_MSCs-EXOs and PEG-HGNs_monocyte-EXOs 
between both cell lines were evaluated when nanopar-
ticles were added (0.125  mg  mL−1) simultaneously to 
a cell co-cultured during 72  h. Secondly, PEG-HGNs 
were previously incubated with MSCs for 24 h and after 
that, 5 × 104 MSCs containing nanoparticles were cul-
tured with 5 × 104 monocytes in an IBIDI μ-Slide 8 well 
as mentioned above. Samples were directly visualized 
by time-lapse microscopy to evaluate the specific trans-
ference of PEG-HGNs in exosomes between MSCs and 
monocytes after 24, 48 and 72  h of culture under the 
different conditions. Frames were taken every 15  min 
for 3  days at 37  °C and under normoxic conditions in 
DIC mode (Leica AF6000 LX, Germany). Finally, an 
image sequence was created and the specific cellular 
transference of PEG-HGNs_MSCs-EXOs between cells 
was tracked using ImageJ software. We created the 
track segments by linking consecutive frames, detect-
ing the transference of nanoparticles between MSCs 
when a monocyte was present.
The selective uptake of exosomes loaded with PEG-
HGNs between monocytes and MSCs under the differ-
ent conditions assayed was also quantified by MP-AES, 
analyzing the gold content present in each cell type as 
well as that present in the supernatant. Again, cells were 
cultured separately or both together. To do that, they 
were seeded onto 6-well plates at a density of 2.5 × 105 
cells per well. Furthermore, 1.25 × 105 monocytes were 
co-cultured with 1.25 × 105 MSCs in the same well. 
After 24  h of maintenance, PEG-HGNs were added 
(0.125 mg mL−1) and incubated for 24 and 48 h. As men-
tioned above, nanoparticles were also pre-incubated 
with MSCs for 24  h and then 1.25 × 105 MSCs loaded 
with PEG-HGNs were put in contact with 1.25 × 105 
monocytes for 24 and 48  h. The experiment was also 
carried out in the same way, but nanoparticles were 
also pre-incubated with monocytes instead of with stem 
cells. Once the cellular pellets were collected, they were 
digested with 10% Aqua regia  (HNO3 + 3HCl) in dH2O 
(1.5  mL). Gold content of supernatants was also meas-
ured. Digestion was performed at room temperature for 
1 h. Total amounts of gold derived from HGNs and PEG-
HGNs was determined by MP-AES using a quadrupole 
mass spectrometer (4100 MP-AES, Agilent Technologies, 
USA). Calibrations were carried out using Au standards 
in 10% regia water ranging from 0 to 10 ppm.
A similar experiment was carried out by firstly puri-
fying PEG-HGNs loaded exosomes from MSCs and 
from monocytes as mentioned above. Later, they were 
added to a co-cultured of MSCs and monocytes for 24 
and 48 h in MW6 as it has been describe. Once cellular 
pellets were collected, their gold content was evaluated 
my MP-AES as explained before.
Cell irradiation. Selective photothermal effect 
of PEG-HGNs_MSCs-EXOs
To study the laser photothermal effect in MSCs, mela-
noma cells (B16-F1 and B16-F10) and monocytes they 
were seeded (1.5 × 104) onto a 48-well plate for 24  h 
after the incubation with PEG-HGNs_MSCs-EXOs. 
The PEG-HGNs_MSCs-EXOs concentration added 
to each well, was estimated as the ratio between the 
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amount of donor cells from which those exosomes 
were derived (MSCs) and the number of treated cells. 
Ten times more of the amount of PEG-HGNs_MSCs-
EXOs produced by seeded cells was also added to 
treated cells. To reduce any possible heating potentially 
produce by non-internalized exosomes present in the 
medium, cells were washed twice with PBS (1500 rpm, 
5  min). All cellular types were then irradiated during 
30 min with a NIR laser (808 nm) at 2.5 W cm−2 of irra-
diance. After that, cells were incubated with the LIVE/
DEAD kit (Thermo Fisher Scientific, USA) following 
manufacturer instructions. Briefly, a solution contain-
ing 2 μM calcein AM and 4 μM ethidium homodimer-1 
in PBS was prepared and added to the cells for 30 min 
at 37  °C. The samples were then visualized under an 
inverted florescence microscope (Olympus IX81) carry-
ing out a malalignment of 4× images to show the whole 
well. Viability and toxicity caused by the laser applica-
tion were also quantified by labeling cells with LIVE/
DEAD kit as mentioned above and using a FACSAria 
BD cytometer (BD Bioscience). MSCs, B16-F1 cells, 
B16-F10 cells and monocytes without treatment were 
also assessed as control samples to obtain the basal via-
bility/cytotoxicity status.
To study in more detail the photothermal applica-
tions, a co-culture of MSCs (previously loaded with 
PEG-HGNs) and B16-F1 was also irradiated to study 
the selective photothermal effect due to the specific 
nanoparticle tracking between cell lines. Therefore, 
MSCs and B16-F1 were co-cultured together onto a 
24-well plate at a density of 2 × 104 MSCs and 2 × 104 
B16-F1 per well. After 24  h, cells were irradiated as 
mentioned above. Finally, they were stained with 
LIVE/DEAD kit (Thermo Fisher Scientific, USA) and 
observed in an IX81 inverted fluorescence microscope 
(Olympus, Japan).
Statistical analysis
The results here expressed as the mean ± standard devia-
tion were carried out in triplicate. The software Stata/SE 
12.0 was used to develop the statistical analyses of the data. 
This analysis was performed using Student’s t-test and one-
way analysis of variance with a normal distribution whereas 
the Wilcoxon Rank-sum test and the Kruskal–Wallis test 
were used for the data groups with a non-normal distribu-
tion. P < 0.05 was considered statistically significant.
Additional files
Additional file 1. Additional figures and tables.
Additional file 2. Time-lapse video.
Additional file 3. Time-lapse video.
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